Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Dabigatran: an oral novel potent reversible nonpeptide inhibitor of thrombin Eisert WG; Hauel N; Stangier J; Wienen W; Clemens A; van Ryn JArterioscler Thromb Vasc Biol 2010[Oct]; 30 (10): 1885-9Dabigatran is a highly selective, reversible, and potent thrombin inhibitor and is orally available as the prodrug, dabigatran etexilate. It has shown antithrombotic efficacy in animal models of thrombosis, with a rapid onset of action and predictable pharmacodynamic response. Peak plasma concentrations of dabigatran occur 1 to 2 hours after ingestion of the prodrug. The terminal half-life of dabigatran is 12 to 14 hours in elderly volunteers. Dabigatran is not metabolized by cytochrome P450 isoenzymes and does not interact with food. Dabigatran has a low potential for drug-drug interactions and is predominantly renally excreted. Dabigatran etexilate as chronic therapy effectively prevents the recurrence of venous thromboembolism and cardioembolic stroke. For the first time, it has been demonstrated clinically that there may be an effective and safe alternative to warfarin.|Administration, Oral[MESH]|Animals[MESH]|Anticoagulants/administration & dosage/chemistry/pharmacokinetics/pharmacology[MESH]|Benzimidazoles/*administration & dosage/chemistry/pharmacokinetics[MESH]|Biological Availability[MESH]|Dabigatran[MESH]|Drug Design[MESH]|Humans[MESH]|In Vitro Techniques[MESH]|Prodrugs/*administration & dosage/chemistry/pharmacokinetics[MESH]|Pyridines/*administration & dosage/chemistry/pharmacokinetics[MESH]|Thrombin/*antagonists & inhibitors[MESH] |
